Join to View Full Profile
1283 York AvenueNew York, NY 10065
Dr. Cigler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2004 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
Duke University School of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2002 - 2027
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors Start of enrollment: 2009 Jul 01
- Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor Start of enrollment: 2012 Aug 07
Publications & Presentations
PubMed
- [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, Andrew Brandmaier, Eleni Andreopoulou
European Journal of Radiology. 2024-12-01 - 7 citationsBenefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.Genevieve A Fasano, Solange Bayard, Yalei Chen, Leticia Varella, Tessa Cigler
Breast Cancer Research and Treatment. 2022-02-01 - 4 citationsUtility of [18F]-Fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from post treatment change in estrogen receptor-posi...Jana Ivanidze, Kritika Subramanian, Trisha Youn, Tessa Cigler, Joseph R. Osborne
Neuro-Oncology Advances. 2021-11-30
Press Mentions
CDC Allocates Funds to Support Initiatives Aimed at Breast Cancer PatientsJanuary 6th, 2025
The Webcam Will See You Now: Doctors Urge Patients to Replace in-Person Visits with AppsMarch 19th, 2020
Scalp Cooling Can Help Some Breast Cancer Patients Retain HairFebruary 27th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
